Founded in 2018, BioMilk company is developing both cow milk as well as breast milk, including immune-boosting carbohydrates. In February, BioMilk completed a merger with publicly traded shell company Fantasy Network, a publicly-traded shell company.
“This is a significant milestone towards the achievement of the company’s goals of accelerating the professional introduction of Bio Milk’s technology and making our cultured milk and breast milk products available to the local and the global market,” said BioMilk CEO Tomer Aizen in a statement. “The investor confidence that we are able to enjoy on TASE will allow us to enhance our development capabilities and bring forward groundbreaking solutions to the local and the global market.”
The funds will be used to add researchers and scale the company’s technology.